Company Information

  

Address: 300 THIRD STREET  
City: CAMBRIDGE 
State: MA 
Zip Code: 02142 
Telephone: (617) 551-8200 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

We are a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes. Since many diseases are caused by the inappropriate activity of specific genes, the ability to silence genes selectively through RNAi could provide a new way to treat a wide range of human diseases. We believe that drugs that work through RNAi have the potential to become a broad new class of innovative medicines, and that this potential new drug class is similar to the opportunity created with other major biological discoveries such as recombinant DNA and monoclonal antibodies. Using our intellectual property and expertise, we are developing what we believe to be a reproducible and modular platform to develop RNAi therapeutics for a variety of human diseases.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2017-5.12NAN/E
03/2017-4.83NAN/E
12/2016-4.79NAN/E
09/2016-4.55NAN/E
06/2016-4.24NAN/E
03/2016-4.04NAN/E
12/2015-3.45NAN/E
09/2015-2.61NAN/E

Key Financial Ratios and Statistics

FYE: 12/31

Profitability 2016 Leverage 2016
Net Inc/Comm Equity-0.16Total Liab/Total Assets0.27
Net Inc/Total Assets-0.32Total Liab/Inv Cap0.30
Net Inc/Inv Cap-0.36Total Liab/Comm Equity0.13
Pretax Inc/Net Sales-8.70Interest Coverage RatioNA
Net Inc/Net Sales-8.70Curr Debt/EquityNA
Cash Flow/Net Sales-6.52LTD/Equity0.16
SG&A/NetSales1.89Total Debt/Equity0.16
Asset Utilization   Liquidity  
Net Receivables Turnover2.98Quick Ratio5.10
Inventory TurnoverNACurrent Ratio5.10
Inventory Day SalesNANet Rec/Curr Assets0.03
Net Sales/Work Cap0.09Inv/Curr AssetsNA
Net Sales/PP&E0.41  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 15.93 18.96 17.45 13.65
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 45.78 38.49 27.88 22.39
Operating Income -120.47 -106.51 -115.43 -106.68
Interest Exp NA NA NA NA
Pretax Income -118.42 -107.29 -112.93 -104.07
Other Income 2.05 -0.78 2.50 2.61
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -118.42 -107.29 -112.93 -104.07

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 923.27 556.92 617.80 699.52
Receivables - Total 15.41 19.46 23.33 15.15
Inventories - Total NA NA NA NA
Total Current Assets 960.71 597.19 671.88 747.56
Net Property, Plant & Equipment 147.53 129.96 114.57 74.22
Total Assets 1,434.28 1,133.93 1,262.81 1,312.91
Liabilities        
Accounts Payable 66.99 57.21 96.58 59.35
Debt in Current Liabilities NA NA NA NA
Total Current Liabilities 108.73 95.79 131.70 81.76
Long-Term Debt 150.00 150.00 150.00 150.00
Total Liabilities 311.32 303.03 342.59 297.94
Stockholder's Equity        
Minority Interest NA NA NA NA
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.92 0.86 0.86 0.86
Retained Earnings -1,882.52 -1,764.10 -1,656.81 -1,543.88
Treasury Stock NA NA NA NA
Total Stockholders' Equity 1,122.97 830.90 920.22 1,014.97
Total Liabilities and Stockholders' Equity 1,434.28 1,133.93 1,262.81 1,312.91

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -81.05 -100.33 -78.34 -75.54
Net Cash Provided by Investing Activities -67.67 75.08 100.39 -31.41
Net Cash Provided by Financing Activities 386.31 2.72 3.08 4.35

Annual Summary Data (Millions)

Year Sales Net Income EPS
12/201266.72-106.01-2.11
12/201347.17-89.22-1.45
12/201450.56-360.40-4.85
12/201541.10-290.07-3.45
12/201647.16-410.11-4.79
Growth Rates-8.31----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/1724587,78095.69




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.